Boxlight BOXL Stock Slides 108 Support at 080 20260518 Air Lease AL Unchanged at 6500 RangeBound Trading 20260515 Myseum MYSE Stock Analysis Falls 055 Watching 171 20260518 Cocrystal COCP Declines 357 Amid Market Weakness 20260515 SEBIs Revised Savings Formula Boosts Indias FY25 Savings Ratio by 47 Basis Points Sundaram Alternates Concludes Record Fundraise for Indias First ESGAligned Real Estate Credit Fund Tech Gains Lift Mixed Markets as Indexes Stay Flat Vertiv VRT Q1 2026 Profit Surges Past Wall Street Targets Trump Signals No Rush on Iran Deal Maintains Naval Blockade US Stock Futures Slide as Putins Nuclear Doctrine Shift Rattles Markets Australian Lithium Miner Accelerates Expansion as Lithium Prices Recover Delivery Hero Shares Surge 10 as Uber Reportedly Revives Takeover Interest Morgan Stanley and Argus Adjust ADP Price Targets After Earnings ReRating Fed Minutes Reveal Officials Anticipate Rate Hikes If Inflation Persists Paramount Skydance Corporation PSKY Q1 2026 Earnings EPS Surges Past Expectations Stock Rises SPB Q1 2026 Earnings Strong EPS Beat Drives Share Gains Despite Missing Revenue Details TaskUs Q1 2026 Earnings EPS Slightly Misses Estimates Stock Rises FRAF Q1 2026 Earnings EPS Beats Estimates Stock Declines Tutor Perini Corporation TPC Q1 2026 Earnings Strong EPS Beat Amid Revenue Disappointment GigaIPOs Signal Structural Challenges in Public Equity Markets GPI Q1 2026 Earnings Miss on EPS Despite Positive Market Reaction NewtekOne Inc 850 Fixed Rate Senior Notes due 2029 NEWTG Q1 2026 Earnings EPS Slightly Misses Estimates Revenue Not Disclosed VRE Q4 2025 Earnings EPS Surprises to the Upside Despite Loss Stock Virtually Flat Runway Growth Finance Corp Q1 2026 Earnings EPS Misses Estimates Amid Stable Portfolio Performance 51Talk COE Q3 2025 Earnings Wider Loss Weighs on Shares as Revenue Details Remain Unclear MoonLake Immunotherapeutics MLTX Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Advances Pipeline CHAI Q4 2025 Earnings Massive Earnings Miss Highlights Ongoing Challenges CRIS Q1 2026 Earnings Significant EPS Miss as Biotech Advances Pipeline Without Revenue